FDA Considers Major Rule Change to Allow Peptides and New Substances in Dietary Supplements

For decades, the rule governing what can be sold as a dietary supplement in the United States has been relatively simple: if it isn't a vitamin, mineral, botanical, or amino acid, it needs to be a substance that humans already consume as part of their normal diet.

But as the wellness industry surges forward with lab-created peptides, precision-fermented enzymes, and novel microbials, that 30-year-old boundary is fracturing. Now, the Food and Drug Administration (FDA) is considering a major regulatory shift that could redefine the supplement aisle, potentially allowing a wave of cutting-edge—and currently restricted—substances to be sold directly to consumers.[1][3]

The tension centers on a single paragraph in the 1994 Dietary Supplement Health and Education Act (DSHEA), known as Clause E. This clause allows for "a dietary substance for use by man to supplement the diet by increasing the total dietary intake." Historically, the FDA has interpreted this strictly, limiting it to conventional food components. Industry advocates argue this interpretation is outdated and stifles innovation, blocking safe, lab-grown ingredients from reaching the public simply because they were not historically found on a dinner plate.[1][3]

The push for modernization reached a boiling point earlier this year. Following a pivotal public meeting in March 2026 and pressure from Health and Human Services Secretary Robert F. Kennedy Jr.—who has vowed to cut red tape for wellness products—the FDA began reviewing nearly 1,000 public comments on whether to expand the "dietary substance" definition. The agency is now weighing how to handle ingredients produced through emerging technologies without compromising public safety.[1][3]

At the heart of this regulatory debate are peptides. Peptides are short chains of amino acids that act as signaling molecules in the body, directing cells to perform specific functions like repairing tissue, regulating hormones, or reducing inflammation. While some peptides, such as the blockbuster weight-loss drug semaglutide, go through years of clinical trials for full FDA approval as prescription medications, many others are caught in a regulatory gray area.[2][5]

Compounds like BPC-157 (often used for joint and gut healing) and TB-500 (used for muscle recovery) are highly sought after in fitness and longevity circles. However, because they are synthesized in a lab and do not have a history as conventional food, they do not currently qualify as dietary supplements. In late 2023, the FDA even restricted compounding pharmacies from producing several of these peptides, citing a lack of sufficient safety data.[2][5]

Because they fall outside the current supplement definition and face compounding restrictions, many popular peptides have been pushed into a sprawling online gray market. They are frequently sold as "research chemicals not for human consumption"—a legal loophole that allows vendors to bypass health regulations. This leaves consumers vulnerable to products that lack standardized manufacturing, accurate dosing, or purity testing, raising the risk of contamination and adverse reactions.[2][5]

Reclassifying certain peptides and novel compounds as dietary supplements would pull them out of this gray market and onto retail shelves. Proponents argue that this would bring much-needed transparency and manufacturing standards to the space. If companies can legally market these substances as supplements, they will be subject to the FDA's Good Manufacturing Practices (GMP), ensuring that what is on the label is actually in the bottle.[1][3]

However, this shift comes with a significant safety trade-off. Dietary supplements are not subject to the FDA's rigorous pre-market approval process. While prescription drugs must prove they are both safe and effective through multiple phases of human clinical trials before they can be sold, supplement manufacturers are only required to ensure their products are safe and truthfully labeled. If powerful biological signaling molecules are reclassified as supplements, they will bypass the clinical trial process entirely.[1][2]

The proposed changes extend far beyond peptides. The FDA is also looking at how to handle ingredients created through cell culture, precision fermentation, and recombinant methods. As food science evolves, the line between a naturally occurring botanical and a lab-optimized microbial is blurring. For example, if a company uses genetically engineered yeast to produce a rare antioxidant found in plants, does that lab-grown compound qualify as a dietary supplement? The FDA's upcoming guidance will have to answer exactly these kinds of questions.[3]

This reevaluation of supplements coincides with broader efforts to track what enters the American body. In August 2026, the FDA proposed a separate rule to end the practice of "self-affirmed" Generally Recognized As Safe (GRAS) ingredients in the food supply. Under the new proposal, manufacturers would be required to notify the FDA before marketing a new food ingredient, closing a loophole that allowed companies to bypass government notification for decades. Together, these moves signal a comprehensive overhaul of how the FDA oversees wellness and nutrition.[4]

For consumers navigating the supplement aisle today, this regulatory flux means you must be your own advocate. If you are considering a novel wellness product—particularly a peptide or a lab-synthesized compound—understand that its presence on a shelf does not equal FDA endorsement of its effectiveness. The burden of proof for supplements is much lower than for medications.[2][5]

Until the new boundaries are officially drawn, practical diligence is essential. Look for products that voluntarily undergo third-party testing for purity and potency, often indicated by seals from organizations like NSF or USP. Most importantly, consult a healthcare provider before introducing biologically active compounds into your routine, especially if you are managing an underlying health condition or taking prescription medications.[2][5]